Flagship Ventures Fund V, L.P. 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-24 5:00 pm Purchase | 2024-05-22 | 13D | Foghorn Therapeutics Inc. FHTX | Flagship Ventures Fund V, L.P. | 16,303,949 22.900% | 3,629,829 (+28.64%) | Filing |
| 2020-10-29 5:00 pm Purchase | 2020-10-27 | 13D | Foghorn Therapeutics Inc. FHTX | Flagship Ventures Fund V, L.P. | 12,674,120 35.500% | 12,674,120 (New Position) | Filing |